SARS News and Research

RSS

Long Covid's hidden healthcare burden: Over 2 million affected in the UK

Healthcare utilization by long coronavirus disease (COVID) or LC patients between January 2020 and 2023.

24 Oct 2023

Is COVID-19 a risk factor for Alzheimer's disease?

The study explores the interconnected risks between COVID-19 and Alzheimer's Disease (AD), highlighting how SARS-CoV-2 can aggravate AD pathology through neuroinflammation and neurodegeneration. It raises significant concerns about the long-term cognitive implications of COVID-19, especially among those already at risk for AD.

23 Oct 2023

Lockdown blues: Study reveals stark impact of COVID-19 on mental health in the UK

Research paper evaluates the mental health impacts of the first COVID-19 wave on U.K. residents, revealing heightened psychological distress particularly among younger people, women, and minority groups. Factors such as financial stress, loneliness, and household density were found to significantly influence the severity of mental health decline during the pandemic.

23 Oct 2023

The transmission dynamics of SARS-CoV-2 among healthcare workers

The transmission of SARS-CoV-2 in hospitals and its impact on the dynamics of the COVID-19 pandemic.

23 Oct 2023

COVID-19 tied to elevated risk of benign prostatic hyperplasia complications

SARS-CoV-2 infection linked to increased benign prostatic hyperplasia (BPH) complications and medication use. Urological manifestations in COVID-19 patients emphasize the importance of awareness among clinicians.

22 Oct 2023

Canine transmission models provide insights into the neurological impacts of COVID-19 on human brains

The histopathologic alteration caused by SARS‑CoV‑2 on mammalian neurological systems.

20 Oct 2023

Low serotonin levels observed in long COVID and other viral infections

Researchers identify a pathophysiological mechanism linking serotonin reduction to the multifaceted etiology of post-acute sequelae of COVID-19.

20 Oct 2023

Study reveals alarming hospital-acquired SARS-CoV-2 transmission rates in England

Study in Nature delves into hospital-acquired SARS-CoV-2 transmission in England, revealing significant numbers of infections and potential implications for community spread, highlighting the importance of robust prevention measures.

20 Oct 2023

NIH renews support for UMass Chan and UMass Lowell’s point-of-care technology initiative

UMass Chan Medical School and UMass Lowell have received an $8.9 million award from the National Institutes of Health (NIH) for renewed support of their initiative to advance the development of home-based and point-of-care health technologies.

19 Oct 2023

MuTaLig: A multi-target paradigm for innovative drug discoveries

Everyone at some point in their life may need to take medication to treat an illness or disease. By finding new and better ways to create drugs, the COST Action Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig) helped improve the effectiveness and safety of the medications, which can ultimately benefit people's health and well-being.

19 Oct 2023

Virginia Tech researchers develop new drug design framework to fight COVID-19

As the COVID-19 pandemic scattered and isolated people, researchers across Virginia Tech connected for a data-driven collaboration seeking improved drugs to fight the disease and potentially many other illnesses.

19 Oct 2023

Do overweight individuals exhibit reduced cardiopulmonary fitness after recovering from COVID-19?

Cardiopulmonary fitness, body composition, and persistent long COVID symptoms of individuals who had SARS-CoV-2 infections.

19 Oct 2023

Assessing COVID-19 vaccine effectiveness against long COVID

Researchers discuss SARS-CoV-2 vaccine effectiveness in preventing long COVID in fully vaccinated individuals.

19 Oct 2023

Pan-coronavirus vaccine shows success in mouse studies

A vaccine designed to protect against three different deadly coronaviruses shows success in mouse studies, demonstrating the viability of a pan-coronavirus vaccine developed by researchers at the Duke Human Vaccine Institute.

18 Oct 2023

Children's immune system better prepared to defend against SARS-CoV-2, study finds

Why are severe courses of SARS-CoV-2 infection much less common in children and adolescents than in adults? Scientists at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have now discovered that the immune system in the upper respiratory tract is much more alert and active in children before infection than in adults and is therefore better equipped to fight the virus.

18 Oct 2023

SARS-CoV-2 infection may worsen lower urinary tract symptoms in men

Research published in the Journal of Internal Medicine indicates that SARS-CoV-2 infection may worsen lower urinary tract symptoms (LUTS) in men.

18 Oct 2023

Review highlights the potential mechanistic links between COVID-19 and Alzheimer's disease

The various neurological symptoms that patients with COVID-19 have experienced suggest that viral infections may increase the risk of neurodegeneration, which could in turn contribute to the development of conditions such as Alzheimer's disease (AD).

18 Oct 2023

Public health interventions prevented most SARS-CoV-2 introductions from leading to outbreaks

SARS-CoV-2, the causative agent of COVID-19, began impacting the U.S. in March 2020 with many schools and universities shifting to remote education by early April 2020 in response to the public health emergency.

17 Oct 2023

Researchers win $5 million grant to expand access to pediatric long COVID-19 care

Researchers at Kennedy Krieger Institute have received a $5 million grant from the U.S. Department of Health and Human Services (HHS), through the Agency for Healthcare Research and Quality (AHRQ), to expand access to comprehensive care for children and adolescents with long COVID-19, particularly among underserved populations.

17 Oct 2023

Paxlovid treatment provides protection against COVID-19 for both mother and child

A new mouse model of infection with the COVID-19-causing SARS-CoV-2 virus during pregnancy tracks closely the disease course doctors have observed in SARS-CoV-2-infected pregnant patients, and suggests that treatment with the antiviral Paxlovid provides protection for both mother and child.

16 Oct 2023

SARS News and Research

Long Covid's hidden healthcare burden: Over 2 million affected in the UK

Is COVID-19 a risk factor for Alzheimer's disease?

Lockdown blues: Study reveals stark impact of COVID-19 on mental health in the UK

The transmission dynamics of SARS-CoV-2 among healthcare workers

COVID-19 tied to elevated risk of benign prostatic hyperplasia complications

Canine transmission models provide insights into the neurological impacts of COVID-19 on human brains

Low serotonin levels observed in long COVID and other viral infections

Study reveals alarming hospital-acquired SARS-CoV-2 transmission rates in England

NIH renews support for UMass Chan and UMass Lowell’s point-of-care technology initiative

MuTaLig: A multi-target paradigm for innovative drug discoveries

Virginia Tech researchers develop new drug design framework to fight COVID-19

Do overweight individuals exhibit reduced cardiopulmonary fitness after recovering from COVID-19?

Assessing COVID-19 vaccine effectiveness against long COVID

Pan-coronavirus vaccine shows success in mouse studies

Children's immune system better prepared to defend against SARS-CoV-2, study finds

SARS-CoV-2 infection may worsen lower urinary tract symptoms in men

Review highlights the potential mechanistic links between COVID-19 and Alzheimer's disease

Public health interventions prevented most SARS-CoV-2 introductions from leading to outbreaks

Researchers win $5 million grant to expand access to pediatric long COVID-19 care

Paxlovid treatment provides protection against COVID-19 for both mother and child

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News